For many pathogenic bacteria like Pseudomonas aeruginosa heme is an essential source of iron. After uptake, the heme molecule is degraded by heme oxygenases to yield iron, carbon monoxide, and biliverdin. The heme oxygenase PigA is only induced under ironlimiting conditions and produces the unusual biliverdin isomers IX␤ and IX␦. The gene for a second putative heme oxygenase in P. aeruginosa, bphO, occurs in an operon with the gene bphP encoding a bacterial phytochrome. Here we provide biochemical evidence that bphO encodes for a second heme oxygenase in P. aeruginosa. HPLC, 1 H, and 13 C NMR studies indicate that BphO is a "classic" heme oxygenase in that it produces biliverdin IX␣. The data also suggest that the overall fold of BphO is likely to be the same as that reported for other ␣-hydroxylating heme oxygenases. Recombinant BphO was shown to prefer ferredoxins or ascorbate as a source of reducing equivalents in vitro and the ratelimiting step for the oxidation of heme to biliverdin is the release of product. In eukaryotes, the release of biliverdin is driven by biliverdin reductase, the subsequent enzyme in heme catabolism. Because P. aeruginosa lacks a biliverdin reductase homologue, data are presented indicating an involvement of the bacterial phytochrome BphP in biliverdin release from BphO and possibly from PigA.
For many pathogenic bacteria like Pseudomonas aeruginosa heme is an essential source of iron. After uptake, the heme molecule is degraded by heme oxygenases to yield iron, carbon monoxide, and biliverdin. The heme oxygenase PigA is only induced under ironlimiting conditions and produces the unusual biliverdin isomers IX␤ and IX␦. The gene for a second putative heme oxygenase in P. aeruginosa, bphO, occurs in an operon with the gene bphP encoding a bacterial phytochrome. Here we provide biochemical evidence that bphO encodes for a second heme oxygenase in P. aeruginosa. HPLC, 1 H, and 13 C NMR studies indicate that BphO is a "classic" heme oxygenase in that it produces biliverdin IX␣. The data also suggest that the overall fold of BphO is likely to be the same as that reported for other ␣-hydroxylating heme oxygenases. Recombinant BphO was shown to prefer ferredoxins or ascorbate as a source of reducing equivalents in vitro and the ratelimiting step for the oxidation of heme to biliverdin is the release of product. In eukaryotes, the release of biliverdin is driven by biliverdin reductase, the subsequent enzyme in heme catabolism. Because P. aeruginosa lacks a biliverdin reductase homologue, data are presented indicating an involvement of the bacterial phytochrome BphP in biliverdin release from BphO and possibly from PigA.
In the presence of a suitable electron donor the enzyme heme oxygenase (HO, 1 EC 1.14.99.3) catalyzes the oxidative degradation of heme to yield equimolar amounts of biliverdin (BV), iron, and CO (see Fig. 1 ). In the well studied eukaryotic HOs, NADPH and NADPH-cytochrome P450 reductase serve as the electron donor (1, 2) . Bacterial HOs have only recently been described, and the HO from Corynebacterium diphtheriae (HmuO) was among the first ones to be discovered (3) . In C. diphtheriae the HO reaction is utilized to release iron from heme under pathogenic (i.e. free-iron limiting) conditions (3) . In fact, the breakdown of heme to mine iron is thought to be the major function of HOs from pathogenic organisms, thus allowing them to overcome the low concentrations of free-iron necessary for successful colonization (infection). Their function in iron utilization has been shown for HOs from several pathogenic bacteria, including Neisseria meningitidis (HemO), Corynebacterium ulcerans (HmuO), and Staphylococcus aureus (IsdG/I) (4 -6) . One of the most interesting bacterial HOs was recently identified in the Gram-negative opportunistic pathogen Pseudomonas aeruginosa. The pigA gene, originally identified in a screen for iron-regulated genes, was shown to encode a protein with homology to the neisserial HOs (7) . The gene, which is part of a five-gene operon (pigA-E), is under the control of the global iron regulator Fur (ferric uptake regulator) and is only expressed under iron-limiting conditions (8) . Unlike all other eu-and prokaryotic HOs that regiospecifically cleave the ␣-meso carbon of heme, PigA targets the ␤-and ␦-meso carbons of the heme macrocycle (7) (Fig. 1) . The unusual production of ␤-and ␦-BV was shown to be due to an unusual seating of the substrate heme in the active site pocket of PigA (9) . The purpose for the production of these BV isomers and their fate in P. aeruginosa, however, is currently unknown. In addition to their function in iron utilization bacterial HOs are also involved in the first step of phycobilin biosynthesis. These linear tetrapyrrole molecules are precursors of the chromophores for the cyanobacterial light-harvesting phycobiliproteins and the photoreceptor phytochrome. Phytochromes are traditionally known as biliprotein photoreceptors in plants but have recently also been discovered in bacteria (10) . Unlike plant and cyanobacterial phytochromes, which carry a phytochromobilin or phycocyanobilin chromophore, bacteriophytochromes (BphPs) from non-photosynthetic prokaryotes have been shown to utilize a BV chromophore (11) . P. aeruginosa was among the first non-photosynthetic bacteria identified to harbor a gene encoding for a BphP. This bacteriophytochrome is a typical sensor kinase of a prokaryotic twocomponent signaling system. The bphP gene is located in an operon downstream from a bphO gene, which encodes a putative HO. So far, no gene encoding for the corresponding response regulator has been identified in P. aeruginosa. Herein we present the first biochemical and biophysical evidence that bphO encodes for a functional HO that oxidizes heme to BV IX␣. Because P. aeruginosa is the first known organism to encode two functional HOs, each capable of oxidizing heme to a different BV isomer, their involvement in phytochrome chromophore biosynthesis has been investigated and will also be discussed.
EXPERIMENTAL PROCEDURES

Reagents
All chemicals, including glutathione-agarose, were purchased from Sigma (Munich, Germany) and were American Chemical Society grade or better. Restriction enzymes were from Invitrogen (Cleveland, OH).
MasterTaq
TM was purchased from Eppendorf Scientific (Westbury, NY). HPLC-grade acetone and 80% formic acid were purchased from Fisher Scientific (Pittsburgh, PA). The expression vector pGEX-6P-1 and PreScission TM protease were obtained from Amersham Biosciences. Centricon-10 concentrator devices were purchased from Amicon (Beverly, MA). Cytochrome P450 reductase was from Merck Biosciences (Bad Soden, Germany), all ferredoxins, ferredoxin-NADP ϩ oxidoreductase, and catalase were from Sigma.
Construction of Expression Vectors
P. aeruginosa PAO I pigA and bphO (PA4116) genes were amplified from chromosomal DNA via polymerase chain reaction with a hot start protocol using the following primers, which contained the indicated and underlined restriction sites: pigABamHIfwd: 5Ј-CGGGATCCGATACC-CTGGCCCCTGAATCC-3Ј, pigAXhoIrev: 5Ј-CCGCTCGAGTCAGGCG-AAGGTACGCTCCAG-3Ј; bphOBamHIfwd: 5Ј-GCGGATCCATCTCCC-CATCTCCATCGCCAGC-3Ј, bphOSmaIrev: 5Ј-TCCCCCGGGTCAGGC-TTCGTCGAGAACCCATC-3Ј. The polymerase chain reaction products were then cut with the indicated enzymes and inserted into similarly restricted pGEX-6P-1. The integrity of the plasmid constructs was verified by complete DNA sequence determination of the insert (Davis Sequencing, Davis, CA). Both constructs placed the heme oxygenase gene downstream of and in frame with the glutathione S-transferase (GST) gene of Schistosoma japonicum under the control of a P tac promoter. A recognition sequence for PreScission protease is located upstream of the cloned gene. Proteolytic cleavage yields the native protein with a small N-terminal extension.
Expression and Purification
Expression and purification were performed according to instructions supplied by the manufacturer (Amersham Biosciences) and as described before (12) . Recombinant P. aeruginosa BphP was expressed using a tet promoter-driven Strep-tag system (13) (IBA, Göttingen, Germany). Details of the cloning and purification will be published elsewhere.
Protein Determination
Protein concentration was determined by the Bradford method with bovine serum albumin as a standard or by measuring the absorbance at 280 nm and using the calculated ⑀ 280 nm for each individual protein (14, 15) .
Spectrophotometric Analysis of Biliverdin Production
The formation of BV IX␣ was detected spectrophotometrically at 450 nm by converting it to bilirubin IX␣ (BR) using recombinant rat biliverdin reductase (BVR) (16) . An aliquot of ϳ5 g of crude recombinant rat BVR (expression clone was a gift of Dr. J. C. Lagarias, University of California at Davis) was added to the purified BphO⅐BV complex in 25 mM HEPES-KOH, 100 mM KCl, 10% glycerol, pH 7.5, and the reaction was started by adding an NADPH-regenerating system containing 6.5 mM glucose 6-phosphate, 0.82 mM NADP ϩ , and 1.1 unit/ml glucose-6-phosphate dehydrogenase.
Reconstitution of BphO with Heme
The BphO⅐heme complex was prepared according to protocols previously described for heme⅐heme oxygenase complexes (3, 17) . Heme was added to purified protein at a final ratio 3:1 heme:protein. Aliquots of heme (1.0 -30 M) were added to the cuvette containing 10 M BphO and to the reference cuvette at room temperature. Spectra were recorded 5 min after heme addition. 
Determination of the Extinction Coefficient for the BphO⅐heme Complex
The millimolar extinction coefficient at 409 nm for the BphO⅐heme complex was determined using the pyridine hemochrome method (2, 18) . The isolated BphO⅐heme complex was converted to a pyridine hemochrome in a 500-l sample volume by the addition of 62.5 l pyridine and 62.5 l of 0.5 N NaOH solution. The spectrum of the oxidized pyridine hemochrome was recorded. An excess of dithionite was added, and the spectrum of the reduced ferrous pyridine hemochrome was recorded. The spectrum of the reduced form minus the spectrum of the oxidized form was calculated at 557 nm. The concentration of heme was determined from the extinction coefficient using an ⑀ 405 nm value of 34,530 M Ϫ1 cm Ϫ1 .
Spectroscopic Characterization of the Catalytic Turnover of the BphO⅐heme Complex
The BphO⅐heme complex (1:3) was prepared as described above and applied to a hydroxylapatite column (0.5 ϫ 1.0 cm) equilibrated with 10 mM potassium phosphate buffer (pH 7.4). The column was washed with the same buffer, and the protein eluted in 200 mM potassium phosphate buffer (pH 7.4). The fractions containing the BphO⅐heme complex were dialyzed against 25 mM HEPES-KOH containing 100 mM KCl and 10% glycerol (pH 7.5).
The standard assay (0.5-ml final volume) contained 10 M BphO⅐heme, 0.15 mg/ml bovine serum albumin, 4.6 M ferredoxin (Spinacea, Porphyra, and Clostridium), 0.025 unit/ml spinach ferredoxin-NADP ϩ oxidoreductase in 25 mM HEPES-KOH buffer (pH 7.5). The reaction was started by addition of the NADPH-regenerating system listed above. Spectral changes between 300 and 800 nm were monitored for 30 min at 37°C. Sodium ascorbate or Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) was added to a final concentration of 5 mM unless otherwise noted. The reaction in the presence of human cytochrome P450 reductase (hCPR) was carried out as described previously by Wilks and Schmitt (3) . When appropriate, catalase from Aspergillus niger was added to reaction cuvettes at a ratio of catalase:BphO⅐heme 0.5:1 immediately before the addition of reductant.
HPLC Analysis of BphO Reaction Products
BphO/PigA assay mixtures were loaded onto a Waters (Milford, MA) C 18 Sep-Pak Light cartridge preconditioned as follows: 3-ml wash with acetonitrile to wet the Sep-Pak, 3-ml wash with MilliQ water, and 3-ml wash with 50 mM 4-methylmorpholine/glacial acetic acid (pH 7.7). After the sample was loaded onto the Sep-Pak, it was washed with 3 ml of 4-methylmorpholine/glacial acetic acid (pH 7.7) followed by 3 ml of 0.1% (v/v) trifluoroacetic acid. The tetrapyrroles were then eluted from the Sep-Pak using 2 ml of 100% acetonitrile. The eluate was dried using a Speed-Vac lyophilizer, and the dried samples were analyzed by HPLC. Samples were first dissolved in 10 l of Me 2 SO and then diluted with 200 l of the HPLC mobile phase. Following brief centrifugation and filtration through a 0.45-m polytetrafluoroethylene syringe filter, bilins were resolved by reversed phase chromatography using an Agilent Technologies 1100 liquid chromatograph. The HPLC column used for all of the analyses was a 4.6-ϫ 250-mm Phenomenex Ultracarb 5-m ODS20 analytical column with a 4.6-ϫ 30-mm guard column of the same material. The mobile phase consisted of acetone:20 mM formic acid (50:50 by volume), and the flow rate was 0.6 ml/min. Eluates were monitored at 650 and 380 nm using an Agilent Technologies 1100 series diode array detector. 
NMR Spectroscopic Characterization of BphO
Preparation of BphO Reconstituted with 13 C-Labeled Heme-13 CLabeled ␦-aminolevulinic acids (ALAs) were used as biosynthetic precursors for the preparation of protoheme IX (heme). ␦- [5- 13 C]Aminolevulinic acid ( [5- 13 C]ALA) and [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]ALA were synthesized utilizing methods described previously (19) . Heme labeled with 13 C was obtained utilizing previously reported methodology (9, 20 -22) developed to take advantage of the fact that the first committed precursor in heme biosynthesis is ALA (23) . Thus, 13 C-labeled heme, which was biosynthesized in Escherichia coli upon addition of suitably labeled ALA, was trapped by simultaneously expressing rat liver outer mitochondrial membrane cytochrome b 5 . The details of the biosynthetic protocol, which entail the expression and purification of outer mitochondrial membrane cytochrome b 5 harboring 13 C-labeled heme, have been presented previously (9, 20 -22) . 13 C-Labeled heme was extracted from outer mitochondrial membrane cytochrome b 5 as follows: pyridine (15 ml) was added to 2.5 ml of 1 mM outer mitochondrial membrane cytochrome b 5 in phosphate buffer ( ϭ 0.10, pH ϭ 7.0). Slow addition of chloroform, typically 10 -12 ml, resulted in the precipitation of the polypeptide, while maintaining the pyridine hemochrome in the supernatant. The latter was subsequently separated from the denatured polypeptide by centrifugation and then dried over anhydrous MgSO 4 . The desiccant was removed by filtration, and the filtered pyridinechloroform solution was transferred to a round bottom flask, where it was concentrated to dryness in a rotary evaporator. Finally, the solid was redissolved in 1.5 ml of Me 2 SO. BphO was reconstituted with a freshly prepared solution of 13 C-labeled heme by titrating it into a 25-ml solution of phosphate buffer ( ϭ 0.10, pH ϭ 7.0) containing ϳ2 mol of BphO until the ratio A 280 /A Soret no longer changed. The resultant solution containing the reconstituted enzyme was incubated at 4°C overnight, then purified by size exclusion chromatography with the aid of a Sephadex G-50 column (90 ϫ 2.6 cm inner diameter) equilibrated and eluted with 10 mM phosphate buffer, pH 7.0 at 4°C. Fractions containing pure protein were concentrated in Amicon centrifugal concentrators to ϳ1 ml and then transferred to smaller Centricon concentrators to exchange the protein into deuterated phosphate buffer, pH 7.0, not corrected for the deuterium isotope effect.
NMR Spectroscopy-1 H and 13 C NMR spectra were acquired on a Varian Unity Inova spectrometer operating at frequencies of 599.740 ( 1 H) and 150.817 ( 13 C) MHz, respectively.
1 H spectra were referenced to the residual water peak at 4.8 ppm, and 13 C spectra were referenced to an external solution of dioxane (60% v/v in D 2 O) at 66.66 ppm. Proton spectra were acquired with pre-saturation of the residual water peak over 10,000 data points, with a spectral width of 24 kHz, a 150-ms acquisition time, a 200-ms relaxation delay, and 1024 scans. 13 C spectra were collected over 12,000 data points, with a spectral width of 60 kHz, a 100-ms acquisition time, a 25-ms relaxation delay, and 400,000 scans. HMQC spectra were typically acquired with spectral widths of 24 kHz for 1 H and 50 kHz for 13 C and a 200-ms relaxation delay. HMQC spectra obtained from samples containing BphO reconstituted with heme labeled at the methyl, propionate-␤, and vinyl-␤ carbons were acquired with refocusing delays based on 1 J CH ϭ 140 Hz, whereas spectra obtained from BphO reconstituted with heme labeled at the meso carbons were acquired with 1 J CH ϭ 180 Hz. Data were collected as an array of 2,000 ϫ 128 points with 512 scans per t 1 increment and processed by zero filling once in t 2 and twice in t 1 to obtain an 8,000 ϫ 8,000 matrix. This was apodized with a 90°-shifted squared sine bell function and Fourier transformed. Water-eliminated Fourier transform-NOESY (24, 25) spectra were acquired with 24 kHz in both dimensions, 2,000 data points in t 2 , 256 increments in t 1 , 352 scans per t 1 increment, and (typically) a 40-ms mixing time. The data were processed by zero filling in both dimensions to obtain an 8,000 ϫ 8,000 matrix, apodized with 90°-shifted squared sine bell, and Fourier transformed.
Gel Permeation Chromatography
An Amersham Biosciences Superdex 200 HR10/30 gel permeation chromatography column was equilibrated in 50 mM TES-KOH buffer, pH 7.5, containing 100 mM KCl and 10% (v/v) glycerol (GPC buffer) at a flow rate of 0.4 ml/min. Standards with known M r (i.e. ␤-amylase 200,000; alcohol dehydrogenase 150,000; bovine serum albumin 66,000; carbonic anhydrase 29,000; and cytochrome c 12,600) were applied to the column (100 g), and their elution volumes were determined spectroscopically at 280 nm. 10 M BphP and 10 M estimated BV (bound to BphO) were applied to the column and chromatographed under conditions identical to those used for the standard proteins. All samples were also monitored at 650 nm for BV detection.
Phytochrome Difference Spectroscopy
To test chromophore assembly of BphP in vitro, 20 M recombinant apo-BphP was incubated with 40 M chromophore or BphO (PigA)⅐BV complex for 30 min at room temperature in darkness. Absorbance spectra were obtained after 3-min incubation with red light at 630 nm (P fr spectrum) and far red light at 750 nm (P r spectrum), respectively, in a volume of 500 l (50 mM HEPES-KOH, 20 mM KCl, pH 8.0) using an Agilent Technologies 8453 Value Analysis UV-Visible System. Difference spectra (P r Ϫ P fr ) were calculated.
Coupled Oxidation of Heme
The four isomers of BV IX were obtained through coupled oxidation of heme in pyridine as described before (26) . The four BV isomers were separated using a semi-preparative reversed phase HPLC of the same material as described above, except that the flow rate was 2 ml/min.
RESULTS
Expression and Purification of Recombinant P. aeruginosa
Heme Oxygenases-The P. aeruginosa pigA and bphO genes were expressed using a tac promoter-driven N-terminal GST fusion expression system. All the reported results were obtained for recombinant BphO unless otherwise noted. Recombinant PigA and BphO could be purified to ϳ99% homogeneity, as shown in Fig. 2A for BphO. One single band was obtained on SDS-PAGE migrating at ϳ23,000, which corresponds to the predicted relative molecular weight calculated from the amino acid composition (M r ϭ 21,465). One liter of bacterial culture typically yielded 10 mg of purified BphO. Interestingly, expression of recombinant protein resulted in the development of a bright green color (Fig. 2B as seen by absorption at 650 nm) indicating the production of BV during the recombinant expression of BphO. The produced BV appears to have a high affinity toward BphO, because the BphO⅐BV complex remained stable throughout the entire purification process; however, the bound BV can be replaced by the substrate heme (see below). The production of BV was further confirmed by its conversion to bilirubin (BR) upon addition of rat biliverdin reductase (BVR). Hence, addition of BVR and NADPH to the purified BphO⅐BV complex resulted in the conversion of the bound BV to BR, which was accompanied by a color change from green to yellow and by the appearance of a peak at 450 nm (Fig. 2B) . For additional confirmation that the production of BV was due to the action of BphO during expression, BphO was expressed under anaerobic culture conditions using nitrate as a terminal electron acceptor. Because any known HO reaction is oxygendependent, no formation of BV should be obtained. As expected, no color formation was observed during anaerobic expression FIG. 5 . HPLC analysis of the reaction products of the two P. aeruginosa heme oxygenases. Purified recombinant BphO and PigA were assayed for HO activity. Bilins were extracted from the incubation mixture using a SepPak C 18 reversed phase cartridge and analyzed by reversed phase HPLC as described under "Experimental Procedures." The HPLC solvent was acetone:20 mM formic acid (50:50, v/v), and the eluate was monitored at 650 nm. The top trace shows the metabolites obtained by the BphO reaction; the bottom trace shows the products of the PigA reaction. Retention times for the four BV IX isomers are indicated by arrows. and purification, but the spectrum of purified recombinant BphO showed a small peak around 420 nm suggesting the formation of a BphO⅐heme complex (Fig. 2B, inset) . These observations taken together demonstrated that recombinant BphO is already active in E. coli, where it must interact with a reducing agent. The nature of this reductant, however, remains to be elucidated.
Heme Binds to BphO-The formation of a BphO⅐heme complex was determined by difference spectroscopy. To this end, equal aliquots of hemin were added to the sample cuvette containing the BV complex of BphO in buffer and to the reference cuvette containing only buffer. Addition of hemin to BphO resulted in the replacement of BV, which was evident from a change in color of the solution, from green to brownish red. The electronic absorption spectrum of the BphO⅐heme complex is different from that of the BphO⅐BV complex and from that of free heme in solution (Fig. 3) . The BphO⅐heme complex has a Soret band at 409 nm, which is close to that reported for other bacterial HO⅐heme complexes (27) . Attempts to calculate the dissociation constant (K d ) did not result in reliable data, which is most likely a consequence of competition between BV and hemin for the binding site in BphO. Efforts to remove the relatively tightly bound BV from BphO prior to the titration experiments failed. The extinction coefficient of the BphO⅐heme complex was found to be 97.6 mM Ϫ1 cm Ϫ1 , a value that appears to be the lowest reported for a bacterial HO.
Spectroscopic Characterization of the Catalytic Turnover of the BphO⅐heme Complex-The catalytic turnover of the ferric BphO⅐heme complex in the presence of spinach ferredoxin and a ferredoxin reductase system (i.e. ferredoxin-NADP ϩ -oxidoreductase and a NADPH-regenerating system) was measured spectrophotometrically. In the presence of reduced spinach ferredoxin the BphO⅐heme complex was immediately converted to the oxyferrous complex, which was accompanied by a shift in the Soret band from 409 to 412 nm and by the appearance of ␤/␣-bands at 545 and 579 nm, respectively (Fig.  4A) . Within 30 min the oxyferrous complex was fully degraded to ferric-BV (Fig. 4A) . Interestingly, when the reaction mixture contains the hydrogen peroxide scavenger catalase in addition to Fd, to rule out non-enzymatic coupled oxidation of the BphO⅐heme complex, the reaction proceeded much slower and was arrested at the oxyferrous stage; the latter remained stable over at least 30 min (Fig. 4B) . Because it has been reported that
FIG. 6. Water-eliminated Fourier transform-NOESY (30°C) spectrum of BphO-CN.
Resonance assignments for heme substituents are obtained by following the dipolar connectivities starting from meso-H ␦ at 7.19 ppm and walking through the macrocycle in two directions: 1) meso-H ␦ 3 1Me 3 2V ␤ 3 2V ␣ 3 meso-H ␣ 3 3Me 3 4V ␤ 3 meso-H ␤ 3 5Me 3 6P ␣ . The 4V ␣ resonance can also be identified by its cross-peak with 4V ␤ ; 2) meso-H ␦ 3 8Me 3 7P ␣ . for some bacterial HOs the Fd-dependent conversion of heme to BV requires a second reductant such as ascorbate (28), ascorbate or Trolox was added to the arrested reaction. This resulted in the full conversion of the oxyferrous complex to iron-free BV, as was evident from the development of green color and from the appearance of a peak at 680 nm (Fig. 4C) . In comparison, ascorbate by itself supported the oxidation of the BphO⅐heme complex to ferric (Fe 3ϩ -) BV (Fig. 4D) . Addition of catalase to the ascorbate-mediated heme degradation did not alter the reaction.
To distinguish the observed spectral changes from a coupled oxidation reaction, the BphO⅐heme complex was incubated with 30 or 300 M H 2 O 2 , respectively. Only the high concentration of H 2 O 2 promoted the coupled oxidation reaction, which resulted in the formation of Fe 3ϩ -verdoheme (Table I) . If the same reaction also contained catalase, no heme degradation was observed, which confirmed that in the presence of peroxides heme in the BphO⅐heme complex was degraded via coupled oxidation.
Reductant Specificity of BphO-The reductant specificity of BphO was tested using several commercially available reductants in our assay system. We tested the Fds from Clostridium sp. [4Fe-4S], Porphyra sp. [2Fe-2S], together with spinach ferredoxin-NADP ϩ oxidoreductase as well as human cytochrome P450 reductase (hCPR). All Fds tested were capable of supporting the degradation of the BphO⅐heme complex, whereas hCPR failed to mediate the oxidation of the BphO⅐heme complex. Furthermore, sodium ascorbate was a potent reducing partner (as described above). Experiments using a single reductant always resulted in the production of ferric-BV. Only if a second reductant was present iron-free BV was the final product. The results are summarized in Table I .
HPLC Analysis of the BphO and PigA Reaction ProductsUpon completion of the Fd-mediated degradation of the BphO⅐heme complex, the reaction products were extracted using C 18 SepPak cartridges and subsequently subjected to reverse phase HPLC. The four BV IX isomers were used as a standard as well as the reaction products of the PigA reaction. Fig. 5 shows a chromatogram confirming that BV IX␣ is the only product of the BphO reaction, whereas PigA produces the ␤-and ␦-isomers of BV IX.
NMR Spectroscopic Characterization of BphO-Chemical shifts for 1 H and 13 C nuclei originating from heme methyl and meso positions of cyanide-inhibited BphO (BphO-CN) were identified with a combination of one-dimensional non-decoupled 13 C and HMQC spectra, according to the assignment Fig. 8 ). The same region of the 1 H NMR spectrum of PigA, where the heme is rotated in-plane ϳ100°r elative to the ␣-biliverdin-producing HOs, shows three heme methyl resonances. These resonances indicate that the proximal histidine-imidazole plane in PigA lies approximately parallel to the ␣-␥-meso axis (see Fig. 8 ).
strategies outlined in previous work (9, 21, 22) . The 1 H resonance assignments corresponding to heme substituents were subsequently obtained from the NOESY map shown in Fig. 6 . The significance of these assignments (summarized in Table II) is presented below.
It has been proposed that the pattern of paramagnetically affected heme methyl resonances in the 1 H NMR spectra of HO enzymes is diagnostic of the heme in-plane orientation, and hence regioselectivity of meso carbon oxidation (9, 21) . For instance, the cyanide-inhibited forms of ␣-biliverdin-producing HO enzymes (HO-CN) exhibit 1 H NMR spectra with only 1 heme methyl resonance above 12 ppm (3Me). Fig. 7 (A and B) illustrates the downfield portion of the 1 H NMR spectra of the ␣-biliverdin producing HmuO-CN and HemO-CN, respectively, with only the 3Me resonance from its major (3Me) and minor (3me) heme orientational isomer resolved from the diamagnetic envelope of resonances (21, 29) . The spectra of the ␣-biliverdinproducing human and rat HO-1-CN enzymes are essentially identical to those shown in Fig. 7 (A and B) (30, 31) . In comparison, the 1 H NMR spectrum of PigA-CN, where the heme is rotated in-plane ϳ100°relative to the heme of the ␣-biliverdinproducing enzymes, exhibits three heme methyl resonances from the more abundant heme orientational isomer (5Me, 1Me, and 8Me) and three from the less abundant isomer (me) (9) (see Fig. 7C ). It is therefore evident from the resolved portion of the 1 H NMR spectrum of BphO⅐CN (Fig. 7D) , which only displays the methyl resonance corresponding to 3Me, that this enzyme should oxidize heme to produce ␣-biliverdin. Indeed, this prediction based on the diagnostic feature of the downfield resolved 1 H NMR spectrum is in good agreement with the fact that assays of heme oxidation regio-selectivity yield only ␣-biliverdin. The plot shown in Fig. 8 permits a straightforward correlation of the observed shifts for the four heme methyl groups as a function of the angle formed between the axial histidineimidazole plane and the molecular x-axis (32) . Interpretation of the heme methyl resonance assignments in the context of this plot made it possible to correctly predict an angle of 125°for the proximal imidazole of human heme oxygenase (32) before the x-ray crystal structure was solved (33) . Moreover, interpretation of the heme methyl resonances from PigA in the context of the plot of Fig. 8 also made it possible to predict (9) that the heme in this enzyme is rotated in-plane ϳ110°relative to the heme in ␣-biliverdin HO enzymes before the x-ray crystal structure of PigA (34) confirmed this prediction. Hence, the order of the heme methyl resonances, 3Me Ͼ 8Me Ͼ 5Me Ͼ 1Me (see Table II ) suggests that the proximal histidine-imidazole plane in BphO forms an angle of ϳ133°with respect to the molecular x-axis, as defined in Fig. 8 . This indicates that the proximal histidine-imidazole plane in BphO lies almost parallel to the ␤-␦-meso axis (shown schematically in Fig. 8 ) as is the case for all ␣-biliverdin producing HOs whose structure is known (human (33) and rat (35) HO-1, HemO (36) , and HmuO (37)).
Interaction between HO⅐BV Complexes and BphP-It has been mentioned above that recombinant BphO purifies as a stable BphO⅐BV complex. The bound BV cannot be removed by gel filtration, ion exchange chromatography, or changes in solution pH, indicating that the release of the BV product is probably the rate-limiting step in this reaction and that BV has -axis (32, 49) . In all ␣-biliverdin-producing HOs, including BphO, the proximal histidineimidazole plane lies nearly parallel to the ␦-␤-meso axis (bottom right). The order and position of the heme methyl chemical shifts in BphO indicate that the angle in this enzyme is ϳ133°(see plot), a value very similar to that seen in the crystal structures of HmuO (37), HemO (36), and HO-1 (33) . The heme methyl chemical shifts of PigA have been used to predict (9) that its heme is rotated in-plane nearly 100°(top right) so that the proximal histidine-imidazole plane lies nearly parallel to the ␣-␥-meso axis and forms an angle of ϳ35°. This prediction was corroborated in the recent crystal structure of PigA (34). a high affinity toward BphO. The release of BV is known to be the rate-limiting step in other HOs. In the case of mammalian HOs the rate limitation is overcome by the presence of BVR, the subsequent enzyme in heme catabolism; the presence of BVR accelerates the release of BV (38) . Because P. aeruginosa lacks a BVR homologue, another enzyme might be involved in the release of BV from BphO. Because the bphO gene is located in an operon together with the gene bphP, which encodes a bacterial phytochrome, we tested the interaction between recombinant BphO and BphP (a) to probe if BphO is able to produce the chromophore for BphP and (b) to investigate if the release of BV is facilitated through the interaction with BphP. Hence, purified BphO⅐BV was incubated with purified apoBphP while monitoring changes in absorbance. The mixture was subsequently subjected to red-and far-red light-induced difference spectroscopy (39) to test for the formation of holoBphP. As shown in Fig. 9A the spectrum of BphO⅐BV changes upon addition of BphP leading to the formation of a photoactive holo-BphP (Fig. 9B) . To further confirm that BphO and BphP interact to transfer the BV produced by BphO to BphP, we subjected both proteins to gel permeation chromatography (GPC) to see whether we obtain any physical interaction between both proteins. As seen in Fig. 9C both proteins by themselves elute as single peaks on a Superdex 200 GPC column (upper two elution profiles). Monitoring the absorbance values at both 280 nm (protein) and 650 nm (BV) confirmed that BphO forms a very stable complex with BV. After incubation of both proteins in a 1:1 ratio and subsequent chromatography, we were still able to separate both proteins from each other. However, a major portion of the absorbance at 650 nm (i.e. BV) was then associated with BphP, indicating that BV was removed from BphO and was attached to BphP. This attachment was identified to be covalent by zinc blotting (40) (data not shown) and is in agreement with other known bacterial phytochromes that form a covalent complex with BV (11, 41) . Experiments to identify real physical interaction between BphO and BphP using the GPC method after Hummel and Dreyer (42) with BphO⅐BV in the mobile phase did not reveal a stable complex of both proteins (data not shown).
Because PigA, the second HO in P. aeruginosa, also purifies as a stable PigA⅐BV complex, similar experiments were performed using the PigA⅐BV complex. Incubation of PigA⅐BV with BphP also resulted in an absorbance change yielding a functional holo-BphP (Fig. 9D) . In contrast to BphO, which only produced the ␣-isomer of BV IX, PigA produced two different isomers of BV IX. Because the purified PigA⅐BV complex most likely consisted of a mixture of PigA⅐BV IX␤ and PigA⅐BV IX␦, it was necessary to establish which BV isomer is responsible for the obtained photoactive phytochrome. Therefore, we obtained each BV isomer through coupled oxidation of heme and tested whether they are able to bind to apo-BphP. As shown in Fig. 10 only the BV isomers IX␣ and IX␦ are able to form a photoactive holo-phytochrome. The ⌬⌬A of the obtained difference spectrum with BV IX␦ is ϳone-fifth of that with BV IX␣ implying a lower affinity of BV IX␦ toward BphP. Furthermore, it was shown that both isomers (␣ and ␦) form a covalent bond with BphP (data not shown). These results indicate that the obtained difference spectrum after incubation of PigA⅐BV with BphP is due to the covalent attachment of BV IX␦ to BphP.
DISCUSSION
bphO Encodes a Second Heme Oxygenase in P. aeruginosaThe Gram-negative opportunistic pathogen P. aeruginosa is the first example of an organism that harbors two heme oxygenases with different regiospecificity of heme cleavage. The PigA enzyme has already been well characterized and is known to be involved in the mining of heme-iron under the free-iron limiting conditions likely to occur during infection of a host cell (7) . On the basis of 1 H NMR and resonance Raman studies, it was recently determined that the unusual regiospecificity of PigA is due to a rotated seating of the heme substrate in the active site pocket (9) . This observation was further confirmed by the recently published crystal structure of PigA (34) . The biological reason for the production of BV IX␤ and BV IX␦, however, remains unknown. In comparison, to date, there is only indirect evidence that bphO genes encode for functional HOs (11) . In this report we present biochemical and biophysical evidence demonstrating that recombinant P. aeruginosa BphO is indeed a heme oxygenase that catalyzes the conversion of heme to BV IX␣.
BphO Prefers Ferredoxins and Ascorbate as Reducing Partners-Most HOs are capable of utilizing an endogenous E. coli electron donor, which is manifested as a green color in E. coli cells expressing HOs (3, 27, 43) . In vitro, however, the activity of most bacterial HOs is usually tested using either mammalian CPR or ascorbate as an electron donor. E. coli possesses several reductants that could possibly serve as electron donors; among them are several Fds and flavodoxin (44) . We therefore tested commercially available Fds, as well as ascorbate, for their ability to serve as electron donors for the P. aeruginosa HOs. Indeed, we were able to show that reduced Fds can serve as the electron donor in the BphO reaction, yielding ferric-BV as the final product. In the presence of catalase the conversion from heme to ferric-BV was arrested at the stage of the oxyferrous complex, suggesting that the conversion of the oxyferrous complex to ferric-BV is partly due to coupled oxidation. Fd has a sufficiently negative reduction potential to reduce O 2 to superoxide (45); hydrogen peroxide is then spontaneously formed through dismutation of the superoxide radical. The presence of H 2 O 2 , which is known to react with Fe II -heme to hydroxylate the heme (46) , is scavenged by the presence of catalase. Only when a second reductant such as ascorbate is added to the reaction mixture, is the oxyferrous complex oxidized to BV, thus indicating that the reaction is catalyzed by BphO. The requirement for a second reductant in addition to Fd is in agreement with observations described for HO from algae, plants, and cyanobacteria (28, 47) . Interestingly, it has been shown that the cyanobacterial HO-1 reaction is also terminated at the oxyferrous complex stage with cytochrome P450 reductase (27) indicating that this is a stable intermediate and that the following steps in the catalytic cycle might require a second reductant. Alternatively, it is also possible that the true physiological reductant in P. aeruginosa is capable of supporting the complete catalytic cycle. In contrast to other described bacterial HOs, hCPR was unable to mediate the conversion of heme to BV by BphO in our assay system, indicating that with regard to the redox partner BphO is quite different from other bacterial HOs and more similar to those described for cyanobacteria and plants. In agreement with many other described HOs, ascorbate is also capable of serving as an electron donor in the BphO reaction. Because catalase has no effect in the ascorbate-supported reaction, no coupled oxidation is involved during catalysis. Therefore it appears that ascorbate is the most efficient reductant tested for the in vitro activity of BphO. The origins of the endogenous reductant in E. coli and the one supporting the activity in P. aeruginosa remain to be elucidated.
The Second HO in P. aeruginosa, BphO, is an ␣-Meso-hydoxylating Enzyme-PigA was initially reported to oxidize heme to produce mostly ␤-biliverdin (7). Subsequent studies established that PigA oxidizes heme to a mixture of ␤-(30%) and ␦-(70%) biliverdin (9) . Further, NMR spectroscopic studies revealed that the heme in PigA is rotated in-plane ϳ100°r elative to the heme in all ␣-hydroxylating heme oxygenase enzymes (9) (see Fig. 11A ). This in-plane rotation locates the ␦-meso carbon within the fold of PigA in the same place where ␣-biliverdin forming HOs place the ␣-meso carbon (9) (see Fig.  11B ). Hence, attack of the ␦-meso carbon in PigA leads to the formation of 70% ␦-biliverdin. Inspection of Fig. 11A also reveals that a 180°rotation of the heme about the ␣-␥-meso axis, a phenomenon common in heme proteins where the heme is not covalently attached to the polypeptide (48) , places the ␤-meso carbon where it is attacked, thus explaining the formation of 30% ␤-biliverdin (9). More recently it has been shown that the heme, in one of the heme orientational isomers of the R177E mutant of C. diphtheriae HmuO, rotates ϳ85°and places the ␤-meso carbon in the place typically occupied by the ␣-meso carbon, which results in the formation of ϳ50% ␤-biliverdin (21) . Results obtained from the NMR spectroscopic analysis of BphO strongly suggest that the fold of BphO is likely very similar to that of the other heme oxygenase enzymes. Moreover, these observations also imply that one of the most important structural differences between the two heme oxygenase enzymes in P. aeruginosa is the in-plane conformation of the heme, with the heme in PigA being rotated ϳ110°relative to that of the heme in BphO. This different in-plane conformation of the heme allows BphO to locate the ␣-meso carbon where it can be hydroxylated by the Fe III -OOH intermediate.
Interaction between BphO and BphP
Facilitates the Release of BV from BphO-Single turnover experiments of human HO-1 have revealed that the release of BV from HO-1 is the rate-limiting step in the conversion from heme to BV (38) . In the presence of BVR, this step is accelerated and one of the earlier electron transfer steps becomes rate-limiting. The data presented here indicate that the bacterial phytochrome BphP from P. aeruginosa whose gene is encoded in the same operon as bphO is able to interact with the BphO⅐BV complex and facilitates the release of BV. The BV is "pulled" out of the HO and forms a stable covalent adduct with BphP, which was confirmed by difference spectroscopy and zinc blotting. BphP is not only able to use iron-free BV as a substrate (as shown with purified BphO⅐BV complex) but also the Fe 3ϩ -BV, which is the product of the Fd-mediated reaction (data not shown). These results indicate that BphO produces the chromophore for the bacterial phytochrome BphP and that the activity of BphO might be regulated through the interaction between BphO and BphP. The biological role of BphP still remains to be elucidated.
In addition to the BphO-BphP interaction, we were able to show that BphP also facilitates the release of BV from PigA. From reports by other groups it is known that an A-ring endo vinyl-group of the BV is necessary for binding to BphP (41) . Therefore, only the BV IX␦ isomer should yield a photoactive holo-BphP. Indeed, using the BV isomers obtained from a coupled oxidation reaction, we were able to show that only BV IX␦ binds to BphP. The attachment was shown to be covalent. This indicates that the release of the bound BV from the HOs is determined by the type of bound BV rather than by the nature of the protein. Therefore, the holo-BphP obtained upon incubation of PigA⅐BV with BphP arises from the release of BV IX␦ from PigA. Because PigA in vitro produces the BV isomers in a ratio of 30:70 (IX␤:IX␦) (9), BV IX␦ is a possible chromophore for BphP, although the amount of resultant holo-BphP is only one-fifth that of the BV IX␣-BphP adduct. This could be due to a lower affinity of BV IX␦ toward BphP. Therefore, the function of this photoactive phytochrome might be different from that with bound BV IX␣. Although we were able to show in this study that BphP is able to bind BV IX␦, its physiological significance remains to be proven, because PigA is only expressed under iron-limiting conditions, and it is presently unknown if BphP is expressed under these conditions as well. The role of the interaction with BphP in controlling enzymatic activity of the two HOs and the physiological consequences of the formed holo-BphP are subjects of continuing efforts in our laboratories.
